MMWR Morb Mortal Wkly Rep. 2021 Apr 2;70(13):467-472. doi: 10.15585/mmwr.mm7013a2.
Transmission of SARS-CoV-2, the virus that causes COVID-19, is common in congregate settings such as correctional and detention facilities (1-3). On September 17, 2020, a Utah correctional facility (facility A) received a report of laboratory-confirmed SARS-CoV-2 infection in a dental health care provider (DHCP) who had treated incarcerated persons at facility A on September 14, 2020 while asymptomatic. On September 21, 2020, the roommate of an incarcerated person who had received dental treatment experienced COVID-19-compatible symptoms*; both were housed in block 1 of facility A (one of 16 occupied blocks across eight residential units). Two days later, the roommate received a positive SARS-CoV-2 test result, becoming the first person with a known-associated case of COVID-19 at facility A. During September 23-24, 2020, screening of 10 incarcerated persons who had received treatment from the DHCP identified another two persons with COVID-19, prompting isolation of all three patients in an unoccupied block at the facility. Within block 1, group activities were stopped to limit interaction among staff members and incarcerated persons and prevent further spread. During September 14-24, 2020, six facility A staff members, one of whom had previous close contact with one of the patients, also reported symptoms. On September 27, 2020, an outbreak was confirmed after specimens from all remaining incarcerated persons in block 1 were tested; an additional 46 cases of COVID-19 were identified, which were reported to the Salt Lake County Health Department and the Utah Department of Health. On September 30, 2020, CDC, in collaboration with both health departments and the correctional facility, initiated an investigation to identify factors associated with the outbreak and implement control measures. As of January 31, 2021, a total of 1,368 cases among 2,632 incarcerated persons (attack rate = 52%) and 88 cases among 550 staff members (attack rate = 16%) were reported in facility A. Among 33 hospitalized incarcerated persons, 11 died. Quarantine and monitoring of potentially exposed persons and implementation of available prevention measures, including vaccination, are important in preventing introduction and spread of SARS-CoV-2 in correctional facilities and other congregate settings (4).
2020 年 9 月 17 日，犹他州惩教设施（设施 A）接到报告，称一名牙科保健提供者（DHCP）在 2020 年 9 月 14 日无症状时曾在设施 A 为被监禁者治疗，实验室确认感染了导致 COVID-19 的 SARS-CoV-2 病毒。2020 年 9 月 21 日，一名曾接受过牙科治疗的被监禁者的室友出现了 COVID-19 类似症状*；两人均被安置在设施 A 的 1 号楼（8 个居住单元中有 16 个被占用的单元之一）。两天后，室友的 SARS-CoV-2 检测结果呈阳性，成为设施 A 首例有已知关联的 COVID-19 病例。2020 年 9 月 23 日至 24 日，对接受 DHCP 治疗的 10 名被监禁者进行筛查，又发现另外 2 人感染了 COVID-19，促使该设施内一个未被占用的单元内对这 3 名患者进行了隔离。在 1 号楼内，停止了集体活动，以限制工作人员和被监禁者之间的互动，防止进一步传播。2020 年 9 月 14 日至 24 日，6 名设施 A 工作人员报告出现症状，其中 1 人之前曾与其中 1 名患者有过密切接触。2020 年 9 月 27 日，在对 1 号楼内所有剩余被监禁者的样本进行检测后，确认爆发了疫情；另外发现了 46 例 COVID-19 病例，已向盐湖县卫生部门和犹他州卫生部门报告。2020 年 9 月 30 日，CDC 与两个卫生部门和惩教设施合作，启动了一项调查，以确定与疫情相关的因素并实施控制措施。截至 2021 年 1 月 31 日，设施 A 共有 2632 名被监禁者中报告了 1368 例（发病率=52%），550 名工作人员中报告了 88 例（发病率=16%）。在 33 名住院被监禁者中，有 11 人死亡。对可能接触者进行检疫和监测，并实施现有预防措施，包括接种疫苗，对防止 SARS-CoV-2 在惩教设施和其他聚集场所的引入和传播非常重要（4）。
